摘要
背景:多重耐药革兰氏阴性病原体对保健系统构成持续的威胁,需要调查新的靶点和分子,以开发抗生素以治疗由MDR细菌病原体引起的感染。 目标:开展多学科方法和开发新型化合物作用于新型抗菌靶标的多种策略至关重要。 N-乙酰葡糖胺-1-磷酸二酰基转移酶/葡糖胺-1-磷酸乙酰转移酶(GlmU)是一种这样的靶点,其涉及在革兰氏阴性和革兰氏阳性细菌中合成肽聚糖和脂多糖,使得GlmU成为开发抗菌药物的有吸引力的靶标。 结果:通过X-射线晶体学研究揭示,GlmU由α螺旋臂连接的两个结构域组成; N-末端尿苷酸转移酶结构域类似于二核苷酸Rossmann折叠,C-末端乙酰转移酶结构域采用左手平行β螺旋结构。 GlmU分子排列成三聚体阵列,乙酰转移酶活性位点在相邻的LβH结构域处形成。已经鉴定了GlmU的乙酰转移酶和尿苷酰转移酶活性的许多有效的抑制剂。 GlmU的乙酰转移酶活性抑制剂包括非特异性巯基反应剂,2-苯基苯并呋喃,芳基胺和芳基磺酰胺。据报道,氨基哌啶基抑制剂抑制hiGlmU的尿苷转移酶活性。 结论:本综述提供了GlmU及其报道的抑制剂结构的洞察,使GlmU成为药物设计的潜在目标。 GlmU是针对革兰氏阴性病原体的药物发现的有希望的靶标,未来的研究应集中在GlmU上,用于开发更有效的用于治疗革兰氏阴性感染的化合物。
关键词: GlmU,肽聚糖,脂多糖,抗生素,芳基磺酰胺,抑制剂。
图形摘要
Current Drug Targets
Title:Mechanism and Potential Inhibitors of GlmU: A Novel Target for Antimicrobial Drug Discovery
Volume: 18 Issue: 14
关键词: GlmU,肽聚糖,脂多糖,抗生素,芳基磺酰胺,抑制剂。
摘要: Background: Multidrug resistant Gram negative pathogens pose a persistent threat to the health care system and require investigation of new targets and molecules for the development of antibiotics to treat infections caused by MDR bacterial pathogens.
Objective: It is essential to work on multidisciplinary approaches and diverse strategies for developing new compounds acting on novel antibacterial targets. N-acetylglucosamine-1-phosphateuridyltransferase/ glucosamine-1-phosphate-acetyltransferase (GlmU) is one such target which is involved in the synthesis of both peptidoglycan and Lipopolysaccharide in Gram negative and Gram positive bacteria making GlmU an attractive target for developing antibacterials.
Results: GlmU, as revealed by X- ray crystallographic studies, is made up of two domains connected by α helical arm; the N-terminal uridyltransferase domain resembles a dinucleotide Rossmann fold and the C- terminal acetyltransferase domain adopts a left handed parallel β helix structure. The GlmU molecules are arranged in a trimeric array, the acetyltransferase active site being formed at the junction of adjacent LβH domain. Many potent inhibitors of both the acetyltransferase and uridyltransferase activity of GlmU have been identified. Inhibitors of the acetyltransferase activity of GlmU include nonspecific thiol reactive agents, 2-phenylbenzofurans, arylamines and arylsulfonamides. A aminopiperidine based inhibitor has also been reported to inhibit uridyltransferase activity of hiGlmU.
Conclusion: The present review provides an insight of the structure of GlmU and its reported inhibitors which make GlmU a potential target for drug designing. The GlmU is a promising target for drug discovery against Gram negative pathogens and future studies should focus on GlmU for the development of more potent compounds for treating Gram negative infections.
Export Options
About this article
Cite this article as:
Mechanism and Potential Inhibitors of GlmU: A Novel Target for Antimicrobial Drug Discovery, Current Drug Targets 2017; 18 (14) . https://dx.doi.org/10.2174/1389450117666160502152011
DOI https://dx.doi.org/10.2174/1389450117666160502152011 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers